Clinical medicine profile
Rotavirus Gastroenteritis Vaccine
Vaccine / immunological product
- Route
- IM / SC / ORAL / ID
- Schedule
- POM
- ATC
- Not assigned
- PPB status
- registered
This profile needs source confirmation
A traceable source link is not attached to this profile. Confirm prescribing decisions against the current SmPC and Kenya STG/EML.
Safety essentials
The information most likely to change a prescribing or dispensing decision.
Contraindications
- Anaphylaxis to prior dose or component.
- Live vaccines contraindicated in significant immunosuppression and usually pregnancy.
- Defer for moderate–severe acute illness.
Precautions
- Observe 15 minutes post-dose if high anaphylaxis concern.
- Correct injection technique and site.
- Report AEFI via national systems.
Dosing matrix
Population and organ-function guidance, shown together for faster comparison.
1ml orally on the inside of the cheek. 1st dose: 6-14 week of age. 2nd dose: 4-24 week of age. The interval between doses should not be less than 4 weeks.
See label paediatric section if present; otherwise use paediatric formulary — do not extrapolate adult doses.
N/A generally.
- CrCl 0–120: Confirm renal dosing in product SmPC / primary label.
N/A generally.
Use, effects & interactions
Indications
- Active immunization of infants against severe gastroenteritis caused by rotavirus, G1 and certain non-G1 serotypes.
- Clinical selection for Rotavirus Gastroenteritis Vaccine should follow culture results where relevant, Kenya STG/EML recommendations, and the current product SmPC.
- Class context: Vaccine / immunological product.
- Confirm site-specific dose, duration and monitoring before prescribing.
Adverse effects
- Local pain, low-grade fever, myalgia.
- Serious: anaphylaxis, vaccine-specific rare events (e.g. intussusception historically with some rotavirus products).
Drug interactions
Open multi-drug checker ↗- Follow Kenya KEPI / MoH schedules.
- Never freeze freeze-sensitive vaccines incorrectly.
- Document batch and site.
- Separate true contraindications from precautions.
Mechanism & disposition
Vaccines present antigen to the adaptive immune system to generate protective antibodies and memory cells without causing full disease (or using attenuated/inactivated/subunit/mRNA platforms).
Read complete mechanism
Vaccines present antigen to the adaptive immune system to generate protective antibodies and memory cells without causing full disease (or using attenuated/inactivated/subunit/mRNA platforms). Immunoglobulins provide passive temporary immunity.
Immune response days–weeks
Months–lifelong (schedule-dependent)
IM / SC / ORAL / ID
Pregnancy, lactation & diet
Inactivated vaccines (e.g. influenza, Tdap) often recommended; live vaccines generally avoided.
Most vaccines compatible; live vaccines usually fine for breastfeeding mother.
Brands & loaded prices
| Brand | Manufacturer | Pack | Observed price |
|---|---|---|---|
| GASTRO | Not recorded | GEL 100ML | KES 193.50Daima Chemist price-list reference ↗ Source date not recorded · verify current price |
Sources & review state
Decision support only. Confirm patient-specific decisions against the current product SmPC, Kenya STG/EML, and professional judgement.